1monon MSN
AstraZeneca CEO says AI is reshaping drug development — and helping boost the odds of success
AstraZeneca CEO Pascal Soriot said AI is helping the company develop medicines faster and make smarter decisions throughout the research process.
Asianet Newsable on MSN
SLS stock sees worst day in over a month — but prediction market flashes 83% odds for November AML trial success
Endpoint Area listed Nov. 30 as the expected catalyst timing for Sellas’ Phase 3 GPS trial.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results